Does the metabolic-syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

Diabetes Care

Volumn 27, Issue 11, 2004, Pages 2676-2681

  Stern, Michael P ^a   Williams, Ken ^a   González Villalpando, Clicerio ^b   Hunt, Kelly J ^a   Haffner, Steven M ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; ETHNOLOGY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; RISK FACTOR; SEX; SMOKING; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; RISK;

EID: 7444269499     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.11.2676     Document Type: Article

References (17)

1. Reaven GM: Banting Lecture: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
3. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
4. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Geneva, World Health Org., 1999 (Tech. Rep. Ser., no. WHO/NCD/NCS/99.2)
5. Stern MP, Williams K, Haffner SM: Identification of individuals at high risk of type 2 diabetes: do we need the oral glucose tolerance test? Ann Int Med 136:575-581, 2002
6. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847, 1998
7. Burke JP, Williams K, Haffner SM, Gonzalez-Villalpando C, Stern MP: Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 24:1573-1578, 2001
8. Stern MP, Fatehi P, Williams K, Haffner SM: Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diabetes Care 25:1851-1856, 2002
9. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics 44:837-845, 1988
10. Ginsburg HN: Treatment for patients with the metabolic syndrome. Am J Cardiol 91 (Suppl. 7A):29E-39E, 2003
11. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF: Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701-710, 1997
12. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen M-R, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689, 2001
13. Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusaol E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716, 2002
14. Hanson RL, Imperatore G, Bennett PH, Knowler WC: Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51:3120-3127, 2002
15. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA: Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070-1077, 2002
16. Girman CJ, Rhodes T, Mercuri M, Pyrörälä K, Kjekshus J, Pederson TR, Beere PA, Gotto AM, Clearfield M, 4S Group, AFCAPS/TexCAPS Research Group: The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93:136-141, 2004
17. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P: Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159:882-890, 2004